| Q34172848 | 17-epiestriol, an estrogen metabolite, is more potent than estradiol in inhibiting vascular cell adhesion molecule 1 (VCAM-1) mRNA expression |
| Q44730458 | Acute effects of testosterone on intracellular Ca2+ kinetics in rat coronary endothelial cells are exerted via aromatization to estrogens |
| Q47563183 | Addition of Estradiol to Cross-Sex Testosterone Therapy Reduces Atherosclerosis Plaque Formation in Female ApoE-/- Mice. |
| Q26749088 | Androgen deprivation therapy and cardiovascular disease: what is the linking mechanism? |
| Q34042948 | Androgen receptor in human endothelial cells |
| Q36766910 | Androgen therapy and atherosclerotic cardiovascular disease. |
| Q47993005 | Androgens modulate male-derived endothelial cell homeostasis using androgen receptor-dependent and receptor-independent mechanisms |
| Q37801387 | Atherosclerosis and sex hormones: current concepts |
| Q36861695 | Basic Science Evidence for the Link Between Erectile Dysfunction and Cardiometabolic Dysfunction |
| Q35143192 | Benefits and risks of testosterone treatment for hypoactive sexual desire disorder in women: a critical review of studies published in the decades preceding and succeeding the advent of phosphodiesterase type 5 inhibitors |
| Q24685498 | Chemistry and structural biology of androgen receptor |
| Q33783494 | Dihydrotestosterone alters cyclooxygenase-2 levels in human coronary artery smooth muscle cells |
| Q38828135 | Effects of Neonicotinoids on Promoter-Specific Expression and Activity of Aromatase (CYP19) in Human Adrenocortical Carcinoma (H295R) and Primary Umbilical Vein Endothelial (HUVEC) Cells. |
| Q44410144 | Effects of sex hormones on inflammatory response in male and female vascular endothelial cells. |
| Q36353275 | Endogenous androgen deficiency enhances diet-induced hypercholesterolemia and atherosclerosis in low-density lipoprotein receptor-deficient mice |
| Q44970299 | Endogenous testosterone increases L-type Ca2+ channel expression in porcine coronary smooth muscle |
| Q43023689 | Endothelial regulation of eNOS, PAI-1 and t-PA by testosterone and dihydrotestosterone in vitro and in vivo |
| Q37257504 | Estrogen receptor beta dependent attenuation of cytokine-induced cyclooxygenase-2 by androgens in human brain vascular smooth muscle cells and rat mesenteric arteries |
| Q24680340 | Expanding the therapeutic use of androgens via selective androgen receptor modulators (SARMs) |
| Q73563388 | Free testosterone plasma levels are negatively associated with the intima-media thickness of the common carotid artery in overweight and obese glucose-tolerant young adult men |
| Q37209917 | Gender and sex hormones in multiple sclerosis pathology and therapy. |
| Q35023822 | Gender differences in cardiovascular disease: hormonal and biochemical influences. |
| Q46637660 | Human umbilical vascular endothelial cells express estrogen receptor beta (ERbeta) and progesterone receptor A (PR-A), but not ERalpha and PR-B. |
| Q37280879 | Hypogonadotrophic hypogonadism in type 2 diabetes |
| Q35753555 | Immunomodulation and vaccination for atherosclerosis |
| Q33844198 | Melatonin modulation of crosstalk among malignant epithelial, endothelial and adipose cells in breast cancer (Review). |
| Q43172139 | Novel electrospun polyurethane/gelatin composite meshes for vascular grafts |
| Q46769445 | PKCdelta mediates testosterone-induced increases in coronary smooth muscle Cav1.2. |
| Q24680373 | Pharmacokinetics and pharmacodynamics of nonsteroidal androgen receptor ligands |
| Q39271087 | Regulation of vascular endothelial growth factor by melatonin in human breast cancer cells |
| Q39171887 | Sex Hormones and Sex Chromosomes Cause Sex Differences in the Development of Cardiovascular Diseases |
| Q37795806 | Sex-Based Differences in Vascular Function |
| Q36346910 | Sexual dimorphism in rodent models of hypertension and atherosclerosis |
| Q37504674 | Sexual dimorphism in the aging kidney: differences in the nitric oxide system |
| Q37192036 | Sexual dimorphism of the aging kidney: role of nitric oxide deficiency |
| Q37484915 | Sexual dimorphism, the aging kidney, and involvement of nitric oxide deficiency |
| Q43171849 | Testosterone and secondary hypertension: new pieces to the puzzle. |
| Q44185072 | Testosterone inhibits tumor necrosis factor-alpha-induced vascular cell adhesion molecule-1 expression in human aortic endothelial cells |
| Q35684578 | Testosterone metabolism, dose-response relationships and receptor polymorphisms: selected pharmacological/toxicological considerations on benefits versus risks of testosterone therapy in men. |
| Q92256319 | Testosterone replacement therapy and cardiovascular risk |
| Q44612936 | Testosterone suppresses endothelium-dependent dilation of rat middle cerebral arteries |
| Q36886122 | Testosterone-derived estradiol production by male endothelium is robust and dependent on p450 aromatase via estrogen receptor alpha. |
| Q35738153 | The aging male: testosterone deficiency and testosterone replacement. An up-date |
| Q36439650 | The androgen metabolite, 5α-androstane-3β,17β-diol, decreases cytokine-induced cyclooxygenase-2, vascular cell adhesion molecule-1 expression, and P-glycoprotein expression in male human brain microvascular endothelial cells |
| Q51549993 | The androgen receptor drives the sex-specific expression of vascular cell adhesion molecule-1 in endothelial cells but not lipid metabolism genes in monocyte-derived macrophages. |
| Q35109134 | The importance of oestrogens in males. |
| Q35617189 | The role of estrogen in cardiovascular disease |
| Q38253965 | Why do statins reduce cardiovascular disease more than other lipid modulating therapies? |
| Q37983641 | Why sex matters: the biological mechanisms of cardiovascular disease. |